Company · CIK 1685428
LumiraDx Ltd
| CIK | 1685428 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-09-29 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271624 | 2023-05-04 | 2023-05-15 | 2 | |
| 333-264609 | 2022-05-02 | 2022-10-05 | 4 | |
| 333-266207 | 2022-07-19 | 2022-07-21 | 3 | |
| 333-252174 | 2021-01-15 | 2021-04-07 | 2 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-05-15 | EFFECTDeclared effective | 333-271624 | 9999999995-23-001441 |
| 2023-05-04 | F-3Shelf registered | 333-271624 | 0001193125-23-135280 |
| 2022-10-05 | EFFECTDeclared effective | 333-264609 | 9999999995-22-002934 |
| 2022-07-21 | 424B4Final prospectus | 333-266207 | 0001193125-22-199269 |
| 2022-07-20 | EFFECTDeclared effective | 333-266207 | 9999999995-22-002118 |
| 2022-07-19 | F-1Registration filed | 333-266207 | 0001193125-22-196573 |
| 2022-06-21 | DRSDraft made public | 377-06232 | 0000950123-22-006884 |
| 2022-06-06 | EFFECTDeclared effective | 333-264609 | 9999999995-22-001700 |
| 2022-05-27 | F-1/AAmendment | 333-264609 | 0001193125-22-162342 |
| 2022-05-02 | F-1Registration filed | 333-264609 | 0001193125-22-136761 |
| 2021-09-03 | EFFECTDeclared effective | 333-257745 | 9999999995-21-003411 |
| 2021-04-20 | DRSDraft made public | 377-04694 | 0000950123-21-004736 |
| 2021-04-07 | RWWithdrawn | 333-252174 | 0001193125-21-108304 |
| 2021-01-15 | F-1Registration filed | 333-252174 | 0001193125-21-010218 |
| 2020-08-03 | DRSDraft made public | 377-03366 | 0000950123-20-007575 |